Effect of Fluvastatin on Lipids and Fibrinolysis in Coronary Artery Disease (Q58823398)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Effect of fluvastatin on lipids and fibrinolysis in coronary artery disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

main subject

lipid

0 references

coronary artery disease

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

M Bevilacqua

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P Bettica

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

T Vago

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Rogolino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

V Righini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E Santoli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G Norbiato

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

84-87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900684-4

Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900684-4

Relationships of plasminogen activator inhibitor-1 to anthropometry, serum insulin, triglycerides and adipose tissue fatty acids in healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900684-4

Dietary regulation of fibrinolytic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900684-4

Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900684-4

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900684-4

Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900684-4

Prospective study of endogenous tissue plasminogen activator and risk of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900684-4

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900684-4

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2896%2900684-4

10.1016/S0002-9149(96)00684-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9024745%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference